Summary of patients treated
Last update: 01.2025

Stem cells therapies

FamiCord Group (together with ist mother company Vita 34) stores over 1,000,000 samples & has supplied stem cells for application in clinic for more than 7000 patients.. We supply for the biggest, specialized in stem cells therapies clinics and we also provide products in GMP standard for clinical trails.

We supply stem cells for standard transplantation and cellular therapies and also provide products in GMP standard for clinical trails.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, such as:

  • hematological
  • neurological
  • ophthalmological
  • orthopedical
  • dermatological (i.e. chronic wounds)

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Couple years later first samples were released to treat FamiCord clients. According to available statistics umbilical cord blood stem cells have been transplanted over 45,000 times , but total number of transplantation (including China) reached over 85 000 patients worldwide. 
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

 

Lp.
Source
Source type
Diagnosis
Medicine Area
Application year
Therapy
Country
Recipient age
1
Cord Tissue
Allogeneic - Related
Chronic renal disease
Endocrinology
2025
Experimental Therapy
Romania
50
2
Cord Tissue
Allogeneic - Related
Autism
Neurology
2025
Experimental Therapy
Romania
6
3
Cord Tissue
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
6
4
Cord Tissue
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
6
5
Cord Tissue
Allogeneic - Related
Autism
Neurology
2024
Experimental Therapy
Romania
6
6
Cord Tissue
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
4
7
Cord Tissue
Allogeneic - Related
Autism
Neurology
2024
Experimental Therapy
Romania
6
8
Cord Tissue
Allogeneic - Unrelated
Degenerative and Traumatic Cartilage
Orthopedy
2024
Experimental Therapy
Poland
50
9
Cord Tissue
Allogeneic - Unrelated
Degenerative and Traumatic Cartilage
Orthopedy
2024
Experimental Therapy
Poland
49
10
Cord Tissue
Allogeneic - Unrelated
Degenerative and Traumatic Cartilage
Orthopedy
2024
Experimental Therapy
Poland
58
11
Cord Tissue
Allogeneic - Unrelated
Graft Versus Host Disease
Hematology
2024
Experimental Therapy
Poland
7
12
Cord Tissue
Allogeneic - Unrelated
Graft Versus Host Disease
Hematology
2024
Experimental Therapy
Poland
15
13
Cord Tissue
Allogeneic - Unrelated
Ovarian Dysfunction
Gynecology
2024
Experimental Therapy
Poland
48
14
Cord Tissue
Allogeneic - Related
Severe Pulmonary Hypertension +Mitral Regurgitation
Cardiovascular/Pulmonary
2024
Experimental Therapy
Romania
2
15
Cord Tissue
Allogeneic - Unrelated
Amyotrophic lateral sclerosis
Neurology
2024
Experimental Therapy
Poland
57
16
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2024
Experimental Therapy
Poland
68
17
Cord Tissue
Allogeneic - Related
Autism
Neurology
2024
Experimental Therapy
Romania
17
18
Cord Tissue
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
7
19
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2024
Experimental Therapy
Poland
61
20
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2024
Experimental Therapy
Poland
45
21
Cord Tissue
Allogeneic - Unrelated
Amyotrophic lateral sclerosis
Neurology
2024
Experimental Therapy
Poland
56
22
Cord Tissue
Allogeneic - Unrelated
Graft-versus-host disease
Hematology
2024
Experimental Therapy
Poland
No data
23
Cord Tissue
Allogeneic - Unrelated
Amyotrophic lateral sclerosis
Neurology
2024
Experimental Therapy
Poland
39
24
Cord Tissue
Allogeneic - Unrelated
GvHD
Neurology
2024
Experimental Therapy
Poland
9
25
Cord Tissue
Allogeneic - Unrelated
Cerebral palsy
Neurology
2024
Experimental Therapy
Poland
5
26
Cord Tissue
Allogeneic - Unrelated
Cerebral palsy
Neurology
2024
Experimental Therapy
Poland
13
27
Cord Tissue
Allogeneic - Unrelated
Leukodystrophy
Neurology
2024
Experimental Therapy
Poland
1
28
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2024
Experimental Therapy
Poland
7
29
Cord Tissue
Allogeneic - Unrelated
Leukodystrophy
Neurology
2024
Experimental Therapy
Poland
1
30
Cord Tissue
Allogeneic - Unrelated
Cerebellar-spinal ataxia
Neurology
2024
Experimental Therapy
Poland
35
31
Cord Tissue
Allogeneic - Unrelated
Leukodystrophy
Neurology
2024
Experimental Therapy
Poland
1
32
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2024
Experimental Therapy
Poland
4
33
Cord Blood
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
11
34
Cord Blood
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
10
35
Cord Blood
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
6
36
Cord Blood
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
4
37
Cord Blood
Autologous
Autism
Neurology
2024
Experimental Therapy
Romania
5
38
Cord Blood
Allogeneic
Cerebral Palsy
Neurology
2024
Experimental Therapy
Poland
3
39
Cord Blood
Allogeneic
Cerebral Palsy
Neurology
2024
Experimental Therapy
Poland
7
40
Cord Blood
Autologous
CP
Neurology
2024
Experimental Therapy
Hungary
4
41
Cord Blood
Autologous
Pervasive Developmental Disorder
Neurology
2024
Experimental Therapy
Poland
3
42
Cord Blood
Autologous
Pervasive Developmental Disorder
Neurology
2024
Experimental Therapy
Poland
5
43
Cord Blood
Autologous
Pervasive developmental disorder
Neurology
2024
Experimental Therapy
Poland
4
44
Cord Blood
Allogeneic - Related
fanconi aplastic anemia
Hematology
2024
Standard Therapy
Turkey
12
45
Cord Blood
Autologous
Neuroblastoma
Neurology
2024
Standard Therapy
Poland
4
46
Cord Blood
Autologous
Pervasive developmental disorder
Neurology
2024
Experimental Therapy
Poland
9
47
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
69
48
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
70
49
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
75
50
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
56
51
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
23
52
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
54
53
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
69
54
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
70
55
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
65
56
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
48
57
Bone Marrow Family
Allogeneic
Acute Myeloid Leukemia
Hematology
2024
Standard Therapy
Germany
72
58
Bone Marrow Family
Allogeneic
Chronic Lymphocytic Leukemia Richter Transformation
Hematology
2024
Standard Therapy
Poland
55
59
Bone Marrow Family
Allogeneic
Chronic Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
63
60
Bone Marrow Family
Allogeneic
Follicular Lymphoma
Hematology
2024
Standard Therapy
Poland
48
61
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2024
Standard Therapy
Poland
65
62
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2024
Standard Therapy
Germany
58
63
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2024
Standard Therapy
Poland
70
64
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome - Refractory Cytopenia Of Childhood
Hematology
2024
Standard Therapy
Poland
14
65
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome/ Myeloproliferative Neoplasms
Hematology
2024
Standard Therapy
Germany
61
66
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome-MPN
Hematology
2024
Standard Therapy
Poland
71
67
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2024
Standard Therapy
Poland
68
68
Bone Marrow Family
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2024
Standard Therapy
Poland
64
69
Bone Marrow Family
Allogeneic
Polycythemia Vera/Myelofibrosis
Hematology
2024
Standard Therapy
Poland
74
70
Bone Marrow Family
Allogeneic
Primary Myelofibrosis
Hematology
2024
Standard Therapy
Germany
62
71
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
68
72
Bone Marrow Family
Allogeneic
myelodysplasia
Hematology
2024
Standard Therapy
United Kingdom
57
73
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Germany
69
74
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
USA
58
75
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
USA
60
76
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2024
Standard Therapy
Poland
71
77
Bone Marrow Family
Allogeneic
High risk Myelodysplastic Syndrome
Hematology
2024
Standard Therapy
Germany
69
78
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
USA
74
79
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
15
80
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
8
81
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
12
82
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
8
83
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
52
84
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
57
85
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
66
86
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
5
87
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
54
88
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
56
89
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
3
90
Bone Marrow
Allogeneic
Adrenoleukodystrophy
Hematology
2024
Standard Therapy
Poland
7
91
Bone Marrow
Allogeneic
Adrenoleukodystrophy
Hematology
2024
Standard Therapy
Poland
7
92
Bone Marrow
Allogeneic
Adrenoleukodystrophy
Hematology
2024
Standard Therapy
Poland
9
93
Bone Marrow
Allogeneic
B-Acute Lymphoblastic Leukemia
Hematology
2024
Standard Therapy
Poland
7
94
Bone Marrow
Allogeneic
Chronic Granulomatous Disease
Hematology
2024
Standard Therapy
Poland
4
95
Bone Marrow
Allogeneic
Chronic Granulomatous Disease
Hematology
2024
Standard Therapy
Poland
41
96
Bone Marrow
Allogeneic
Chronic Lymphocytic Leukemia Richter Transformation
Hematology
2024
Standard Therapy
Poland
55
97
Bone Marrow
Allogeneic
Chronic Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
67
98
Bone Marrow
Allogeneic
Chronic Myelogenous Leukemia
Hematology
2024
Standard Therapy
Poland
12
99
Bone Marrow
Allogeneic
Diffuse Large B-Cell Lymphoma
Hematology
2024
Standard Therapy
Poland
61
100
Bone Marrow
Allogeneic
Genetically Determined Thrombocytopenia
Hematology
2024
Standard Therapy
Poland
4
page
of 74
Loading